Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still falling short of demand, the Food and Drug Administration says, and many Americans who rely on these ...
Recent press reports and other evidence suggest that Medicare Part D plans may be encouraging the use of brand-name drugs instead of generics. However, the scope of such practices is unclear. We ...
Pharmaceutical maker Teva has agreed to a settlement of $512 million in a class action lawsuit over the wakefulness drug Provigil. Drug wholesalers and retailers claimed a generic version of the drug ...
In September 1984, the Drug Price Competition & Patent Term Restoration Act, commonly known as the Hatch-Waxman Act for its congressional sponsors’ names, was signed into U.S. law. By creating a new ...
How can the U.S. government lower the high price of prescription drugs? It may need to look to tech entrepreneur Mark Cuban for answers. Medicare could have saved nearly $4 billion in 2020 by ...
A new court ruling has the future use of skinny labels in question, but skinny-label generics have saved Medicare a lot of money over 5 years. Skinny labels, which carve out patent-protected ...
Annabelle C. Fowler, Charles River Associates, Boston, Massachusetts. Ruben Jacobo-Rubio, Food and Drug Administration, Silver Spring, Maryland. Jing Xu ([email protected]), Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback